APLP1 as a Cerebrospinal Fluid Biomarker for Γ-Secretase Modulator Treatment

Alzheimer's Research and Therapy - United Kingdom
doi 10.1186/s13195-015-0160-z
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

A Γ-Secretase Inhibitor, but Not a Γ-Secretase Modulator, Induced Defects in BDNF Axonal Trafficking and Signaling: Evidence for a Role for APP

PLoS ONE
Multidisciplinary
2015English

Neurogranin as a Cerebrospinal Fluid Biomarker for Synaptic Loss in Symptomatic Alzheimer Disease

JAMA Neurology
Neurology
2015English

Γ-Secretase

Science-Business eXchange
2012English

Cerebrospinal Fluid P-Tau217 Performs Better Than P-Tau181 as a Biomarker of Alzheimer’s Disease

Nature Communications
AstronomyGeneticsMolecular BiologyBiochemistryChemistryPhysics
2020English

Cerebrospinal Fluid Outflow Resistance as a Diagnostic Marker of Spontaneous Cerebrospinal Fluid Leakage

Journal of Neurosurgery: Spine
MedicineSurgeryNeurology
2017English

The Amyloid-Β Oligomer Count in Cerebrospinal Fluid Is a Biomarker for Alzheimer's Disease

Journal of Alzheimer's Disease
GerontologyClinical PsychologyMental HealthPsychiatryGeriatricsMedicineNeuroscience
2013English

Phosphatidylcholine PC Ae C44:6 in Cerebrospinal Fluid Is a Sensitive Biomarker for Bacterial Meningitis

Journal of Translational Medicine
BiochemistryMedicineGeneticsMolecular Biology
2020English

Γ-Secretase Inhibitors and Modulators for Alzheimer’s Disease

Journal of Neurochemistry
BiochemistryMolecular NeuroscienceCellular
2011English

Papillomavirus Infection Requires Γ Secretase

Journal of Virology
Insect ScienceImmunologyMicrobiologyVirology
2010English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy